Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Low-Dose Neuromuscular Blocking Agents on Perioperative Complications During Bronchoscopic Procedures
NCT07035301Completed
- Sponsor
- Harbin Medical University
- Start
- Mar 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of rocuronium in Respiratory system disease (2 arms), sponsored by Harbin Medical University. Primary endpoint: Incidence rate of laryngeal spasm. Started Mar 2025; status: completed.
02
Drugs
rocuronium
03
Conditions
Respiratory system disease
Beyond the preview
Go deeper on NCT07035301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07035301.